Table 3.

IOP Safety Parameters in Study Eyes (Safety Population)

Parameter, n (%)*	DEX (N = 145)	Laser (N = 129)
AE*	59 (40.7)	5 (3.9)
IOP at any time during the study
≥25 mmHg	49 (33.8)	6 (4.7)
≥35 mmHg	3 (2.1)	0 (0)
Increase of ≥10 mmHg from baseline	48 (33.1)	2 (1.6)
Use of IOP-lowering topical medication during the study	50 (34.5)	3 (2.3)
Surgical procedure during the study to lower IOP	1 (0.7)†	0 (0)

Notes: *Any treatment-emergent AE related to elevated IOP, ^†Trabeculectomy.

Abbreviations: AE, treatment-emergent adverse event; DEX, dexamethasone intravitreal implant 0.7 mg; IOP, intraocular pressure.